Upgrade to SI Premium - Free Trial

Mizuho Securities Cuts Price Target on Teva Pharma (TEVA) Following 2Q Beat

August 8, 2016 6:53 AM
Mizuho Securities maintained a Buy rating on Teva Pharma (NYSE: TEVA), and cut the price target to $70.00 (from $75.00) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles